HomeAI · summaries
Storia in 7 fonti
Definium's LSD drug clears bar in first of two Phase 3 anxiety disorder trials
Definium Therapeutics oral LSD candidate DT120 has passed a late-stage study in generalized anxiety disorder (GAD), not even two months after reporting trial success for in depression.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
Psychedelics developer Definium scores more positive data for LSD pill
Results from a late-stage study focused on generalized anxiety disorder were a “clean win” to analysts, who believe Definium has a drug with multibillion-dollar sales potential.
- ·
endpoints.news
Definium's LSD drug clears bar in first of two Phase 3 anxiety disorder trials
Definium Therapeutics oral LSD candidate DT120 has passed a late-stage study in generalized anxiety disorder (GAD), not even two months after reporting trial success for in…
